The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy of pegvorhyaluronidase alfa (PEGPH20) plus FOLFIRINOX in a preclinical model of human pancreatic ductal adenocarcinoma.
 
Jesse Bahn
Employment - Halozyme
Stock and Other Ownership Interests - Halozyme
 
Feng Gao
Employment - Halozyme
 
Xiaoming Li
Employment - Halozyme
Stock and Other Ownership Interests - Halozyme
 
Susan Zimmerman
Employment - Halozyme
Stock and Other Ownership Interests - Halozyme
 
Kelly Chen
Employment - Abbott Laboratories (I); Halozyme
Stock and Other Ownership Interests - Halozyme; Halozyme
 
Chunmei Zhao
Employment - Halozyme
Stock and Other Ownership Interests - Biogen; Biogen (I); Halozyme; Halozyme (I); Ignyta; Ignyta (I)
 
Daniel C. Maneval
Employment - Halozyme
Leadership - Halozyme
Stock and Other Ownership Interests - Halozyme
Research Funding - Halozyme
Patents, Royalties, Other Intellectual Property - Halozyme
Travel, Accommodations, Expenses - Halozyme
 
Curtis Thompson
Employment - Halozyme
Stock and Other Ownership Interests - Halozyme
Patents, Royalties, Other Intellectual Property - Halozyme